Y-D Xu Selected Research

Long Noncoding RNA

12/2020	Long noncoding RNA OR3A4 promotes cisplatin resistance of non-small cell lung cancer by upregulating CDK1.
5/2019	Long noncoding RNA OR3A4 promotes cisplatin resistance of non-small cell lung cancer by upregulating CDK1.
5/2019	LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
5/2019	LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis.
4/2019	LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Y-D Xu Research Topics

Disease

2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 05/2019
2	Stomach Neoplasms (Stomach Cancer) 05/2019 - 04/2019
1	Obstructive Sleep Apnea 01/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022
1	Ischemic Stroke 01/2022
1	Stroke (Strokes) 01/2022
1	Atrial Fibrillation 01/2022
1	Neoplasms (Cancer) 05/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2019
1	Neoplasm Metastasis (Metastasis) 04/2019
1	Hypoxia (Hypoxemia) 04/2019
1	Nasopharyngeal Carcinoma 11/2008
1	Osteoradionecrosis 11/2008

Drug/Important Bio-Agent (IBA)

5	Long Noncoding RNAIBA 12/2020 - 04/2019
3	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 05/2019
1	Small Nucleolar RNA (snoRNA)IBA 05/2019
1	multidrug resistance-associated protein 1IBA 04/2019
1	Sirolimus (Rapamycin)FDA Link 04/2019

Therapy/Procedure

1	Wearable Electronic Devices 01/2022
1	Catheter Ablation 01/2022
1	Radiotherapy 11/2008